+------------------------------------------------------------------------------+
BN 02/06 10:22 *ASTRAZENECA: IF WE SAW BIG DEAL THAT MADE SENSE, WOULD CONSIDER BN 02/06 10:22 *ASTRAZENECA CEO: DON'T NEED TO DO LARGE ACQUISITIONS BN 02/06 10:22 *ASTRAZENECA CEO: STILL INTERESTED IN DEAL OPPORTUNITIES BN 02/06 10:21 *ASTRAZENECA: NEED A LOT LESS BUSINESS DEVELOPMENT THIS YEAR BN 02/06 10:21 *ASTRAZENECA: NOW FOCUSED ON DELIVERING LATE-STAGE PRODUCTS BN 02/06 10:21 *ASTRAZENECA: 2013 DEALS FOCUSED ON REBUILDING PHASE 2, 3 LINEUP BN 02/06 10:19 *ASTRAZENECA CEO: ROOM FOR BOTH ADVAIR, SYMBICORT IN U.S. BN 02/06 10:15 *ASTRAZENECA SEEING A BIT LESS PRICING PRESSURE IN EUROPE BN 02/06 10:14 *ASTRAZENECA: ONGOING PRICE PRESSURE IN U.S.; MORE CHALLENGING BN 02/06 10:13 *ASTRAZENECA IN TALKS WITH GERMAN AUTHORITIES ON FORXIGA PRICE BN 02/06 10:13 *ASTRAZENECA SEES CHINA GROWTH CONTINUING, ESPECIALLY SYMBICORT BN 02/06 10:13 *ASTRAZENECA: CHINA IS A NICE STORY FOR US; CO. IS NO. 2 THERE BN 02/06 10:02 *ASTRAZENECA: ABOUT 50% OF 2014 R&D SPENDING ON LATE DEVELOPMENT BN 02/06 10:00 *ASTRAZENECA: WILL FILE OLAPARIB IN U.S. THIS YEAR BN 02/06 09:59 *ASTRAZENECA'S BRIGGS MORRISON COMMENTS ON MEDIA CALL BN 02/06 09:59 *ASTRAZENECA: MAY BE ABOVE 7 NME PHASE 3 STARTS IN 2013-14 BN 02/06 09:56 *ASTRAZENECA: FORECAST ASSUMES U.S. NEXIUM GENERIC IN MAY BN 02/06 09:48 *ASTRAZENECA: RESPIRATORY FRANCHISE DOING `EXTREMELY WELL' BN 02/06 09:47 *ASTRAZENECA: WENT FROM 12TH TO 9TH IN JAPAN LAST YEAR BN 02/06 09:47 *ASTRAZENECA: SIGNIFICANTLY OUTPACING MARKET IN CHINA BN 02/06 09:46 *ASTRAZENECA: CHINA IS MOST IMPORTANT EMERGING MARKET BN 02/06 09:46 *ASTRAZENECA: GROWING ALMOST 20% IN CHINA BN 02/06 09:46 *ASTRAZENECA: GROWTH RATE IN EMERGING MARKETS STEADY FOR YEAR BN 02/06 09:45 *ASTRAZENECA: EXENATIDE SHARE IS GROWING, IN U.S. IN PARTICULAR BN 02/06 09:43 *ASTRAZENECA; STUDIES WILL HELP UNLOCK POTENTIAL OF BRILINTA BN 02/06 09:42 *ASTRAZENECA CEO: CONTINUING TO INVEST IN BRILINTA BN 02/06 09:40 *ASTRAZENECA: SEVERAL HUNDRED RELOCATING TO CAMBRIDGE THIS YEAR BN 02/06 09:37 *ASTRAZENECA: U.S., EUROPE AFFECTED BY GENERICS, GOVT POLICY BN 02/06 09:36 *ASTRAZENECA CEO: CAN RETURN TO GROWTH FASTER THAN PEOPLE EXPECT BN 02/06 09:35 *ASTRAZENECA CEO: `WE ARE ON A JOURNEY' BN 02/06 09:35 *ASTRAZENECA CEO: WE GAINED MOMENTUM IN 2013 BN 02/06 09:34 *ASTRAZENECA 4Q EARNINGS MEDIA CALL BEGINS
+------------------------------------------------------------------------------+
Astrazeneca CEO Would Consider Big Deal if Made Sense 2014-02-06 10:27:03.206 GMT
By Tim Barwell Feb. 6 (Bloomberg) -- CEO says co. doesn’t need to do large acquisitions, though still interested in deal opportunities. * Comments on call with reporters * NOTE: Astra said earlier it has cash, cash equivalents of $9.2b at Dec. 31
Link to Company News:{AZN LN <Equity> CN <GO>}
For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}
To contact the editor responsible for this story: Tim Barwell at +44-20-7073-3512 or tbarwell@bloomberg.net